Logo
  • Getting Started
  • Cancer Topics
  • Nutrient Database
  • Blog
  • Resources
Subscribe

Vitamin D

Getting StartedGetting Started👋About Anticancer.ca🔬Cancer Topics🫐Nutrient Database🧠Anticancer AI🍽️Meal Plan Generator

Vitamin D

image

What Is It?

Vitamin D3{_3}3​ is classified as a nutrient, hormone, and compound that enhances the immune system1{^1}1. It can be sourced by the skin from sunlight, a process also referred to as cutaneous synthesis. However, if an individual is not getting enough ultraviolet light B (UV-B), vitamin D is naturally occurring in many foods2{^2}2, and can be consumed as a nutrient in the diet3{^3}3. Vitamin D3{_3}3​ is a form of vitamin D that works to enhance intestinal absorption of calcium and phosphorus4{^4}4. Vitamin D3{_3}3​ is essential in conserving a proper calcium concentration in blood serum in order to maintain normal musculoskeletal function5{^5}5.  Calcium and phosphorus are minerals that play a crucial role in bone growth, and they also are involved in reabsorption of calcium from the distal tubule of the kidney6,7^{6,7}6,7.  

What Are Its Other Names?

Vitamin D3{_3}3​ is also referred to as cholecalciferol, calcitriol, calcifediol, calciol, (1),25-hydroxyvitamin D, or 25(OH)D. Its molecular formular is C27_{27}27​H44_{44}44​O, and its IUPAC ID is (3β,5Z,7E)-9,10-secocholesta- 5,7,10(19)-trien-3-ol)8^{8}8. Vitamin D2{_2}2​, the structurally identical compound excluding the side chain9^{9}9, is referred to as ergocalciferol10^{10}10. 

Vitamin D3 Chemistry

Vitamin D3{_3}3​ is a secosterol2^{2}2, which means that it is a steroid with a broken bond in its ring9^{9}9. The C9-C10 bond of ring B in vitamin D is broken9^{9}9. Structurally, vitamin D3_{3}3​ and vitamin D2{_2}2​ differ in the side chains9^{9}9. Two chemical reactions take place in human skin in order to produce vitamin D. The first is between 7-dehydrocholesterol and ergosterol, a process which requires sunlight or UV-B. The second is heat isomerization9^{9}9. 

What Are The Sources of Vitamin D3?

Sunlight Absorption of sunlight by the skin is the most prominent source of vitamin D3{_3}3​. However, this can decrease with certain varying characteristics of individuals such as age, skin type, and lifestyle choices such as sunscreen application or clothing. Melanin absorbs UV radiation, thus individuals with more melanin (darker skin tones) in their skin use the sun less efficiently for the production of vitamin D3{_3}3​. More melanin increases amount of sun exposure required for vitamin D3{_3}3​11^{11}11. Vitamin D3{_3}3​ synthesis can also be restricted based on weather, timing, and location, all of which may alter one’s exposure to the sun. An example of these factors is the lower levels of Vitamin D3{_3}3​ that Black or Hispanic individuals residing in temperate latitudes have. Therefore, it might be essential to add certain foods into daily diets in order to optimize vitamin D3{_3}3​ retention. Exposure to UV radiation can be equal to 1000 international units of vitamin D3{_3}3​. In the ideal circumstance or environment, 15 minutes of full-body exposure to sunlight can mean 10,000 international units of vitamin D3{_3}3​12^{12}12. 

What Foods Have It?

Foods containing vitamin D3{_3}3​ are not always obvious or regular dietary choices, and thus extra consideration might need to be applied when deficiency is suspected12^{12}12. 

Food
Serving Size
IU per Serving 
Reference 
Cod Liver Oil 
1 tablespoon
1360 
12
Rainbow Trout
3 Ounces 
645
12
Sockeye Salmon
3 Ounces 
570
12
Raw Mushrooms (UV light exposed)
½ Cup
366
12
Sardines (Oiled and Drained)
2 Sardines
46
12
Scrambled Egg
1 Large
44
12
Beef Liver (Braised) 
3 Ounces 
42
12
Tuna Fish (Watered and Drained) 
3 Ounces
40 
12
Cheddar Cheese
1 Ounce
12
12
Portabella Mushrooms (Diced and Raw) 
½ Cup
4
12
Roasted Chicken Breast
3 Ounces
4
12
Ground Beef (90% Lean) (Broiled) 
3 Ounces 
1.7
12

Fortified Foods

The fortification of foods is when the concentration of a micronutrient is increased in a food that is more commonly consumed. This is done to either improve the nutrient content of that food or to restore nutrients that are lost during food processing13^{13}13. 

Food
Serving Size
IU per Serving
Reference
Milk (2%) 
1 Cup 
120
12
Soy, Almond, Oat Milk
1 Cup
100-144
12

What Are Its Main Benefits?

Half of the people in the world have vitamin D insufficiency. Moreover, 1 billion people worldwide are deficient in the nutrient11^{11}11. There are essential benefits to having sufficient vitamin D, such as bone strength, muscle strength, cancer prevention, cardiovascular health, and support of the immune system. Treatment can be done with either D2{_2}2​ or D3{_3}3​11^{11}11.  Bone Strength Vitamin D increases absorption of calcium by 15-25% and phosphorus by 20%. The concentration of minerals within the bone is maximized when blood levels of 25-hydroxyvitamin D exceed 40 ng/mL, but are decreased when the level is less than 30 ng/mL12^{12}12. Vitamin D deficiency can cause rickets and osteomalacia, diseases indicating weak or soft bones in children and adults, respectfully13^{13}13. If vitamin D3{_3}3​ deficiencies occur during fetal development or during childhood, bones will lack calcium. If the deficiency persists, parathyroid glands will be overactivated which can lead to secondary hyperparathyroidism14,15^{14,15}14,15. If an individual has a malabsorption disease; inflammatory bowel disease, pancreatic insufficiency, celiac disease, cystic fibrosis, cholestatic liver disease, or short bowel disease, they are likely to be deficient in vitamin D due to its fat-soluble nature and absorption facilitated by bile salts in the intestine12^{12}12.  Cancer Prevention Participant-level data from 5706 patients with colorectal cancer and 7107 control participants in 2018 demonstrated that higher blood levels of the circulating form of Vitamin D3{_3}3​, 25-hydroxyvitamin D (25(OH)D), are associated with a reduced risk of colorectal cancer in women and men, but these reductions were only statistically significant in women. The recommended 25(OH)D concentration from this study was 75-100 nmol/L. This is more than the recommendation provided by the Institute of Medicine in the United States16^{16}16.  In addition to being linked with a lower risk of colorectal cancer, serum levels of 25-hydroxyvitamin D3{_3}3​ (25(OH)D) are also known to lower cases of 12 other cancers including breast, ovarian, prostate, pancreatic, and renal17,18^{17,18}17,18.   One review projected that raising the recommended Vitamin D3{_3}3​ intake could prevent over fifty-thousand new breast cancer cases, and almost fifty-thousand new colorectal cancer cases. This review also estimates that a recommended intake of 2,000 IU/day of vitamin D3{_3}3​, for individuals in North America  could lead to a 25% reduction in incidence of breast cancer and a 27% reduction in incidence of colorectal cancer17^{17}17. Although these numbers are estimates and are likely aggressive, they demonstrate the potential benefits of vitamin D3{_3}3​ supplementation. Skin cancer is a disease with complexity regarding vitamin D3{_3}3​ and cancer prevention. This is because vitamin D3{_3}3​ can be synthesized on the skin through absorption of sunlight (cutaneous synthesis).  However, being exposed to an excess amount of sunlight is also a risk factor for nonmelanoma skin cancer. Some forms of moderate exposure to sunlight or vitamin D3{_3}3​ intake can help reduce the risk of developing melanoma skin cancer, which is the most fatal type of skin cancer. It can also reduce the number of cases of non-Hodgkin’s Lymphoma19^{19}19. It is recommended to be exposed to the sun without sunscreen for 5 to 30 minutes a day multiple times in a week. This is because SPF that is less than or equal to 8 can block the absorption of UVB rays from the 7-dehydrocholesterol in the skin. The downstream effects of this would be the inability to convert sun exposure to pre-vitamin D3{_3}3​ and then the inability to isomerize this into vitamin D3{_3}3​20^{20}20.  Cardiovascular Health Metabolites of vitamin D influence pathways that result in decreased atherosclerosis (a process wherein arterial walls thicken due to plaque buildup), decreased high blood pressure, decreased aneurysm-related phenotype, decreased blood clotting, decreased calcium build-up (which could lead to a hardening of tissues), and decreased hypertrophic cardiomyopathy21^{21}21.  Immune System Vitamin D3{_3}3​ plays a role in ensuring the healthy functioning of the immune system, specifically with regards to suppressor T cells, cytokine formation, and programmed cell death12^{12}12.  This is also related to colorectal cancer prevention as vitamin D bound to its receptor can help control inflammatory bowel diseases such as Crohn’s disease and Irritable Bowel Syndrome that may increase the risk of colorectal cancer22^{22}22. 

What Are Its Main Drawbacks?

Since one of the main ways to acquire Vitamin D3{_3}3​ is through exposure to sun and absorption by the skin, it is a drawback that there is no agreement on how much exposure to sunlight is actually safe12^{12}12. Toxicity Vitamin D toxicity is a rare illness that occurs when vitamin D is consumed in excess, which would be around 100 000 international units every day for at least 6 months. Vitamin D toxicity can cause abnormally high levels of calcium or phosphorus in the blood, which can lead to calcium in the coronary arteries and in the kidney19^{19}19. 

What Are Its Mechanisms of Action?

  1. Inhibition of Tumor Cell Growth and Increased Apoptosis : In various types of cancer, calcitriol contributes to arresting the cell cycle in the G0/G1 phase. This inhibits the tumor from growing out of control. It does so by upregulating and downregulating respective genes18^{18}18. While vitamin D3{_3}3​ is not directly responsible for programmed cell death, it can upregulate proteins that are pro-apoptotic such as BAX or G0S2, while downregulating anti-apoptotic proteins such as thymidylate synthase or BCL-2 18,22^{18,22}18,22. This is specific for colon, breast, and prostate cancers in the epithelial tissues. In ovarian epithelial tissue cancer, it activates caspase 9, which is essential to the apoptotic pathway, and inactivates telomerase reverse transcriptase18^{18}18. Telomerase reverse transcriptase is responsible for the stability of chromosome and thus is crucial to the survival of cells which can lead to the development and progression of cancer23^{23}23.  
  2. Vitamin D Receptor Pathway: Autophagy is a cellular process by which energy is conserved through the self-degradation of unnecessary or damaged cellular elements. It is involved in the prevention of cancer through stimulating cellular senescence and the presentation of cell surface antigens as well as the prevention of necrosis and genomic instability24^{24}24. Through binding to the vitamin D Receptor, 1,25-(OH)2{_2}2​D3{_3}3​ and other ligands of the receptor can induce genes responsible for the process18^{18}18.   
  3. Wnt/β-Catenin Pathway : If a mutation occurs in the Wnt/β-Catenin pathway, either by overexpression of the pathway’s factors and receptors or the repression of the pathway's inhibitors, there is the potential for the transformation of healthy cells into cancer cells. In colorectal cancer, 94% of the tumors or metastases are positive for a mutation in this pathway. However, the pathway mutations are also found in a variety of other cancers including blood cell, liver, or lung cancers. Vitamin D3{_3}3​ may decrease nuclear concentrations of β-Catenin, a protein which forms complexes with T-cell factor to promote cell endurance or proliferation of cancer cells. There are two mechanisms by which this occurs, either through the vitamin D/vitamin D receptor complex binding to nuclear β-Catenin to inhibit complex formation, or the plasma membrane localization of β-Catenin following its synthesis to prevent nuclear localization18^{18}18.   

What Are Typical Doses?

The optimal level of 25(OH)D that maximizes the aforementioned benefits is more than 30 ng/mL. Any level between 20 and 30 ng/mL is considered Vitamin D insufficiency. Any level less than 20 ng/mL is considered vitamin D deficiency25,26^{25,26}25,26.  Differences between D3{_3}3​ and D2{_2}2​:  Vitamin D3{_3}3​ is derived primarily from UVB in cutaneous synthesis in comparison to from the diet. Vitamin D2{_2}2​ is derived from plants and the exposure of yeast to radiation11^{11}11. Vitamin D3{_3}3​ is more potent and wears off slower than Vitamin D2{_2}2​27^{27}27.  Vitamin D3{_3}3​ and Calcium  Research has shown that combining vitamin D3{_3}3​ and calcium can have a positive effect on cancer prevention28^{28}28. 29 of the studies included in the summary tables created from reviewing randomized control trials involved the co-administration of vitamin D3{_3}3​ and calcium. This combination was used for both cancer prevention, as well as during treatment or following a cancer diagnosis. The mechanism for the positive effects of combining the two nutrients has been proposed to be due to the vitamin D ultraviolet metabolite, which has beneficial impacts on the metabolism or absorption of calcium29^{29}29. Calcium is linked to decreasing epithelial hyperproliferation in the colon, which is usually initiated by bile and fatty acids. It also decreases ornithine decarboxylase, an enzyme that promotes the formation of tumors. Additionally, there have been studies where calcium has inhibited the development of colon cancer cells in a laboratory setting30^{30}30. Vitamin D3{_3}3​ and Omega-3   Out of the studies used to create the summary tables, 5 included co-administration of vitamin D3{_3}3​ and Omega-3. Research has demonstrated that Omega-3 might play a role in preventing the development of cancer by inhibiting inflammation and uncontrollable cell proliferation, and by preventing tumors from growing blood vessels31^{31}31. One proposed mechanism of cancer suppression through cell death is ferroptosis, which is the intracellular destruction of cells with iron32^{32}32, and it has been proposed that Omega-3 supresses cancer in this manner31^{31}31. 

Summary of Data

Summary of clinical trials administering vitamin D3{_3}3​ on its own for prevention 

Cancer Type
General Effect (% based on number of studies with positive or negative effects) 
Evidence (number of studies; participants)
Any Invasive Cancer
100% reported no significant effects
3; 28,366 participants
General
100% reported no significant effects
2; 7,493 participants
Breast Cancer
100% reported no significant effects
1; 208 participants
Prostate Cancer
100% reported it was well tolerated
1; 105 participants

Summary of clinical trials administering vitamin D3{_3}3​ as an adjunct to therapy + surgery (adjunct to treatments) for preventing recurrence

Cancer Type
General Effect (% based on number of studies with positive or negative effects)
Evidence (number of studies; participants)
Colorectal Cancer
60% reported beneficial effects  20% reported it was well tolerated 20% reported no significant effects
5; 352 participants
Melanoma
100% reported beneficial effects
1; 104
Brain Tumour 
100% reported beneficial effects
1; 60
Digestive Tract Cancer
75% reported beneficial effects 25% reported no significant effects
4; 1598
Breast Cancer
50% reported beneficial effects 25% reported it was well tolerated 25% reported harmful effects (fatigue)
4; 390
Advanced Metastatic Cancer
100% reported beneficial effects
1; 65
Leukemia 
50% reported beneficial effects in patients with low baseline lumbar BMD 50% reported no significant effects
2; 78
Head and neck squamous cell carcinomas
100% reported beneficial effects
1; 32
Prostate Cancer 
66.67% reported beneficial effects 16.6% reported no significant effects 16.6% reported harmful effects 
6; 1,600
Endometrial Hyperplasia 
100% reported beneficial effects
1; 60
Cervical Intraepithelial Neoplasia
100% reported beneficial effects
2;116

Summary of clinical trials administering vitamin D3{_3}3​ + Calcium for prevention 

Cancer Type
General Effect (% based on number of studies with positive or negative effects)
Evidence (number of studies; participants)
General
20% reported beneficial effects 80% reported no significant effects
5; 45,056 participants
Any Invasive Cancer
100% reported no significant effects
1; 36,282 participants 
Breast Cancer
100% reported no signficiant effects
2; 36,612 participants
Colorectal Cancer
25% reported beneficial effects 25% reported differential effects (beneficial or harmful) depending on use of estrogen therapy 25% reported no significant effects 25% were inconclusive 
4; 36,394 participants
Skin Cancer 
100% reported beneficial effects in women with a history of nonmelanoma skin cancer
1; 36,282 participants

Summary of clinical trials administering vitamin D3{_3}3​ + Calcium as an adjunct to therapy + surgery (adjunct to treatments).

Cancer Type
General Effect (% based on number of studies with positive or negative effects)
Evidence (number of studies; participants)
Colorectal
53% reported beneficial effects 13.3% reported harmful effects depending on genotype and on risk of sessile serrated adenomas or polyps 13.3% reported it was well-tolerated 20.3% reported no significant effects
15; 8,723
Keratinocyte Carcinomas
100% reported beneficial effects
1; 2,259
Leukemia 
100% reported no significant effects
1; 275

Summary of clinical trials administering vitamin D3{_3}3​ + Omega for prevention. 

Cancer Type
General Effect (% based on number of studies with positive or negative effects)
Evidence (number of studies; participants)
General
100% reported beneficial effects
1; 25,871 participants
Any Invasive Cancer
100% reported no significant effects
1; 15,917 participants
Colorectal Adenomas and Serrated Polyps
100% reported beneficial effects in those with low baseline vitamin D  
1; 25,871 participants

Summary of clinical trials administering vitamin D3{_3}3​ + Omega as an adjunct to therapy + surgery (adjunct to treatments)

Cancer Type
General Effect (% based on number of studies with positive or negative effects)
Evidence (number of studies; participants)
Colorectal Cancer
100% reported beneficial effects
2; 177 participants

Summary of clinical trials administering vitamin D3{_3}3​ in palliative care

Cancer Type
General Effect (% based on number of studies with positive or negative effects)
Evidence (number of studies; participants)
Advanced Cancers
100% reported beneficial effects
2; 680 participants

Below are links to detailed vitamin D human clinical trial study notes analyzed by Anticancer.ca.

📄 Detailed vitamin D (administered alone for cancer prevention) study notes analyzed by Anticancer.ca

📄 Detailed vitamin D (as adjuvant to therapy + surgery) human clinical trial study notes analyzed by Anticancer.ca

📄 Detailed vitamin D and calcium (for prevention) human clinical trial study notes analyzed by Anticancer.ca

📄 Detailed vitamin D and calcium (as adjunct to therapy + surgery) human clinical trial study notes analyzed by Anticancer.ca

📄 Detailed vitamin D and omega-3 (for prevention) study notes analyzed by Anticancer.ca

📄 Detailed vitamin D and omega-3 (as adjunct to therapy + surgery) human clinical trial and association study notes analyzed by Anticancer.ca

📄 Detailed vitamin D (for palliative care) human clinical trial and association study notes analyzed by Anticancer.ca

References

  1. Sassi F, Tamone C, D’Amelio P. Vitamin D: Nutrient, Hormone, and Immunomodulator. Nutrients. 2018;10(11):1656. doi:10.3390/nu10111656.
  2. Hossein-nezhad A, Holick MF. Vitamin D for Health: A Global Perspective. Mayo Clinic Proceedings. 2013;88(7):720-55. doi: 1016/j.mayocp.2013.05.011.
  3. Carlberg C. Vitamin D. Reference Module in Biomedical Sciences. 2016. doi: 1016/B978-0-12-801238-3.99495-9.
  4. Lips P. Vitamin D physiology. Progress in Physics and Molecular Physiology. 2006;92(1):4-6. doi: 1016/j.pbiomolbio.2006.02.016.
  5. Chauhan K, Shahrokhi M, Huecker MR. Vitamin D. StatPearls. Accessed September 21, 2023.https://www.ncbi.nlm.nih.gov/books/NBK441912/
  6. Shaker JL, Deftos L. Calcium and Phosphate Homeostasis. Endotext. Accessed September 21 2023. https://www.ncbi.nlm.nih.gov/books/NBK279023/
  7. DeLuca HF. The Metabolism and Functions of Vitamin D. Steroid Hormone Resistance. 1985;196. doi:1007/978-1-4684-5101-6_24.
  8. pubchem.ncbi.nlm.nih.gov. Accessed September 21, 2023. https://pubchem.ncbi.nlm.nih.gov/compound/Cholecalciferol
  9. Ohyama Y, Shinki T. Chapter 97 – Vitamin D Derivatives. Handbook of Hormones. 2016:546-7. doi: 1016/B978-0-12-801028-0.00097-0.
  10. G R, Gupta A. Fortification of Foods with Vitamin D in India. Nutrients. 2014;6(9):3601-23. doi: 3390/nu6093601.
  11. Nair R, Maseeh A. Vitamin D: The “sunshine” vitamin. J Pharmacol Pharmacother. 2012;3(2):118-26.
  12. Dominguez LJ, Farruggia M, Veronese N, et al. Vitamin D Sources, Metabolism, and Deficiency: Available Compounds and Guidelines for Its Treatment. Metabolites. 2021; 11(4): 255. doi: 3390/metabo11040255.
  13. Rejnmark L. Effects of Vitamin D on Muscle Function and Performance: A Review of Evidence from Randomized Controlled Trial. The Adv Chronic Dis. 2011; 2(1): 25–37. doi: 1177/2040622310381934.
  14. Holick MF. Vitamin D Deficiency. N Engl J Med 2007; 357:266-81. doi: 10.1056/NEJMra070553.
  15. Muppidi V, Meegada SR, Rehman A. Secondary Hyperparathyroidism. Accessed September 21, 2023. https://www.ncbi.nlm.nih.gov/books/NBK557822/#:~:text=Parathyroid%20hormone%20(PTH)%20is%20secreted,%5D%20Secondary%20hyperparathyroidism%20(SHPT)%20is
  16. McCullough ML, Zoltick ES, Weinstein SJ, et al. Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts. JNCI: Journal of the National Cancer Institute. 2019;111(2):158-69. doi: 1093/jnci/djy087.
  17. Garland CF, Gorham ED, Mohr SB, et al. Vitamin D for Cancer Prevention: Global Perspective. Annals of Epidemiology. 2007;19(7): 468-83. doi: 1016/j.annepidem.2009.03.021.
  18. Muñoz A, Grant WB. Vitamin D and Cancer: An Historical Overview of the Epidemiology and Mechanisms. Nutrients. 2022;14(7):1448. doi: 3390/nu14071448.
  19. Holick MF. Sunlight, UV Radiation, Vitamin D, and Skin Cancer: How Much Sunlight Do We Need? Advances in Experimental Medicine and Biology. 2022;1268. doi: 10.1007/978-3-030-46227-7_2.
  20. Srivastava, SB. Vitamin D: Do We Need More Than Sunshine? 2021;14(4):397-401. doi: 10.1177/15598276211005689.
  21. Norman PE, Powell JT. Vitamin D and Cardiovascular Disease. Circulation. 2014;114:379-93. doi: 10.1161/CIRCRESAHA.113.301241.
  22. Byers SW, Rowlands T, Beildeck M. Mechanism of action of vitamin D and the vitamin D receptor in colorectal cancer prevention and treatment. Reviews in Endocrine and Metabolic Disorders. 2012;13:31-8. doi:1007/s11154-011-9196-y.
  23. Encyclopedia of Cancer. Accessed September 21, 2023. https://www.sciencedirect.com/topics/neuroscience/telomerase-reverse-transcriptase#:~:text=The%20human%20telomerase%20reverse%2Dtranscriptase%20(TERT)%20gene%20encodes%20a,immortalization%2C%20cancer%20development%20and%20progression.
  24. Glick D, Barth S, Macleod KF. Autophagy: cellular and molecular mechanisms. J Pathol. 2010;221(1):3-12.doi: 1002/path.2697.
  25. Ringe JD, Kipshoven C. Vitamin D-insufficiency. Dermatoendocrinol. 2012;4(1): 72–80. doi: 4161/derm.19829.
  26. Holick MF. VITAMIN D STATUS: MEASUREMENT, INTERPRETATION AND CLINICAL APPLICATION. Ann Epidemiol. 2009;19(2):73-8. doi: 1016/j.annepidem.2007.12.001.
  27. Armas LAG, Hollis BW, Heaney RP. Vitamin D Is Much Less Effective than Vitamin D in Humans. 2004;89(11): 5387-91. doi: 1210/jc.2004-0360.
  28. Meinrad P, Grant WB, Cross HB. Calcium, Vitamin D and Cancer. 2009; 29(9): 3697-3698.
  29. Garland CF, Garland FC, Gorham ED. Can colon cancer incidence and death rates be reduced with calcium and vitamin D? The American Journal of Clinical Nutrition. 1991;54(1):193S-201S. doi:10.1093/ajcn/54.1.193s.
  30. Pence BC. Role of calcium in colon cancer prevention: Experimental and clinical studies, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 1993; 290(1): 87-95.
  31. Bischoff-Ferrari HA, Willett WC, Manson JE, Dawson-Hughes B, Manz MG, Theiler R, Braendle K, Vellas B, Rizzoli R, Kressig RW, Staehelin HB, Da Silva JAP, Armbrecht G, Egli A, Kanis JA, Orav EJ, Gaengler S. Combined Vitamin D, Omega-3 Fatty Acids, and a Simple Home Exercise Program May Reduce Cancer Risk Among Active Adults Aged 70 and Older: A Randomized Clinical Trial. Front Aging. 2022; 3: 852643. doi: 10.3389/fragi.2022.852643.
  32. Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Molecular Cancer. 2022; 21: 47.

About This Article

Last Updated
July 3, 2024
Author
Ashiana Sunderji
Editor
Adin Aggarwal
Reviewer and Supervisor
Kenneth W. Yip

Disclaimer

The content on Anticancer.ca is intended for educational and informational purposes only and does not serve as a substitute for professional medical advice or services. Consult a licensed physician for personalized medical advice or questions about your health. Do not disregard professional advice or delay seeking help based on information found on our website. In case of a medical emergency, call 911 or visit the nearest emergency room immediately.

Anticancer.ca strives to provide accurate and reliable information but cannot guarantee its error-free or comprehensive nature. We are not responsible for the quality or endorsement of information, services, products, treatments, or therapies provided by third parties mentioned on our website. Always consult a qualified healthcare professional before making medical decisions.

← Previous

Nutrient Database

Next →

Meal Plan Generator

  • Vitamin D
  • What Is It?
  • What Are Its Other Names?
  • Vitamin D3 Chemistry
  • What Are The Sources of Vitamin D3?
  • What Foods Have It?
  • What Are Its Main Benefits?
  • What Are Its Main Drawbacks?
  • What Are Its Mechanisms of Action?
  • What Are Typical Doses?
  • Summary of Data
  • References
  • About This Article
  • Disclaimer

About us

Contact us

Subscribe to our newsletter

© 2025 Anticancer.ca Inc.

InstagramYouTube